Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novo-Nordisk A/S

69.23
+3.635.53%
Post-market: 69.700.4700+0.68%19:58 EDT
Volume:13.47M
Turnover:931.59M
Market Cap:307.32B
PE:22.04
High:69.86
Open:69.75
Low:68.53
Close:65.60
Loading ...

BMO Capital Downgrades Novo Nordisk to Market Perform From Outperform, Adjusts Price Target to $64 From $105

MT Newswires Live
·
17 Apr

Novo Nordisk Cut to Market Perform From Outperform by BMO Capital

Dow Jones
·
17 Apr

Novo Nordisk : Bmo Cuts to Market Perform From Outperform; Cuts Target Price to $64 From $105

THOMSON REUTERS
·
17 Apr

Eli Lilly's Mounjaro Launch Triggers Weight-Loss Drug Craze In India, Novo Nordisk Seeks To Move Up Wegovy Launch

Benzinga
·
17 Apr

Novo Nordisk downgraded to Market Perform from Outperform at BMO Capital

TIPRANKS
·
17 Apr

Analysts Conflicted on These Healthcare Names: Novo Nordisk (NVO) and Sanofi (OtherSNYNF)

TIPRANKS
·
17 Apr

Novo Nordisk A/S (NVO): A Bull Case Theory

Insider Monkey
·
17 Apr

Novo Nordisk price target lowered to DKK 700 from DKK 900 at Barclays

TIPRANKS
·
17 Apr

Eli Lilly Stock Down 8.2% in a Month: Should You Buy the Dip?

Zacks
·
16 Apr

Counterfeit Ozempic Identified in US Supply Chain With Fake Labels And Needles, FDA Alerts

Benzinga
·
16 Apr

Pfizer Halts Obesity Pill Development Amid Safety Concerns

Zacks
·
16 Apr

BNP Paribas Initiates Novo Nordisk at Underperform Rating, $61 Price Target

MT Newswires Live
·
16 Apr

NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback

Zacks
·
15 Apr

US Begins Probes into Pharmaceutical, Chip Imports, Setting Stage for Tariffs

Reuters
·
15 Apr

Tap Into the Silver Economy Boom With These Aging Demographics Stocks

Zacks
·
15 Apr

Pharmaceutical Stocks Trim Their Gains. Trump Says Pharmaceutical Tariffs in Not Too Distant Future

Tiger Newspress
·
15 Apr

Novo Nordisk A/S Stock Rises Monday, Underperforms Market

Dow Jones
·
15 Apr

Novo Nordisk warns consumers about counterfeit Ozempic injections

TIPRANKS
·
14 Apr

Pfizer just had a big setback in its race for an Ozempic competitor

Quartz
·
14 Apr

Pfizer discontinues GLP-1 pill trial, stock trades flat

Yahoo Finance
·
14 Apr